These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 23483972)
1. Targeted deletion of fibrinogen like protein 1 reveals a novel role in energy substrate utilization. Demchev V; Malana G; Vangala D; Stoll J; Desai A; Kang HW; Li Y; Nayeb-Hashemi H; Niepel M; Cohen DE; Ukomadu C PLoS One; 2013; 8(3):e58084. PubMed ID: 23483972 [TBL] [Abstract][Full Text] [Related]
2. Targeted disruption of fibrinogen like protein-1 accelerates hepatocellular carcinoma development. Nayeb-Hashemi H; Desai A; Demchev V; Bronson RT; Hornick JL; Cohen DE; Ukomadu C Biochem Biophys Res Commun; 2015 Sep; 465(2):167-73. PubMed ID: 26225745 [TBL] [Abstract][Full Text] [Related]
3. Plasma Fibrinogen-Like 1 as a Potential Biomarker for Radiation-Induced Liver Injury. Han NK; Jung MG; Jeong YJ; Son Y; Han SC; Park S; Lim YB; Lee YJ; Kim SH; Park SC; Lee HJ Cells; 2019 Sep; 8(9):. PubMed ID: 31489941 [TBL] [Abstract][Full Text] [Related]
4. Targeting fibrinogen-like protein 1 is a novel therapeutic strategy to combat obesity. Wu HT; Chen SC; Fan KC; Kuo CH; Lin SY; Wang SH; Chang CJ; Li HY FASEB J; 2020 Feb; 34(2):2958-2967. PubMed ID: 31908014 [TBL] [Abstract][Full Text] [Related]
5. Hepatocyte-derived FGL1 accelerates liver metastasis and tumor growth by inhibiting CD8+ T and NK cells. Xi F; Sun H; Peng H; Lian Z; Wei H; Tian Z; Sun R; Chen Y JCI Insight; 2024 May; 9(13):. PubMed ID: 38973608 [TBL] [Abstract][Full Text] [Related]
6. Implication of the hepatokine, fibrinogen-like protein 1 in liver diseases, metabolic disorders and cancer: The need to harness its full potential. Liu XH; Qi LW; Alolga RN; Liu Q Int J Biol Sci; 2022; 18(1):292-300. PubMed ID: 34975333 [TBL] [Abstract][Full Text] [Related]
7. Female Nur77-deficient mice show increased susceptibility to diet-induced obesity. Perez-Sieira S; Martinez G; Porteiro B; Lopez M; Vidal A; Nogueiras R; Dieguez C PLoS One; 2013; 8(1):e53836. PubMed ID: 23342015 [TBL] [Abstract][Full Text] [Related]
8. FGL1 and FGL2: emerging regulators of liver health and disease. Chen J; Wu L; Li Y Biomark Res; 2024 May; 12(1):53. PubMed ID: 38816776 [TBL] [Abstract][Full Text] [Related]
9. Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant. Liu Z; Ukomadu C Biochem Biophys Res Commun; 2008 Jan; 365(4):729-34. PubMed ID: 18039467 [TBL] [Abstract][Full Text] [Related]
10. A Double-Antibody Sandwich ELISA for Sensitive and Specific Detection of Swine Fibrinogen-Like Protein 1. Zhang X; Zhu H; Zheng X; Jiao Y; Ning L; Zhou EM; Mu Y Front Immunol; 2021; 12():670626. PubMed ID: 33968077 [TBL] [Abstract][Full Text] [Related]
11. Ablation of the ID2 gene results in altered circadian feeding behavior, and sex-specific enhancement of insulin sensitivity and elevated glucose uptake in skeletal muscle and brown adipose tissue. Mathew D; Zhou P; Pywell CM; van der Veen DR; Shao J; Xi Y; Bonar NA; Hummel AD; Chapman S; Leevy WM; Duffield GE PLoS One; 2013; 8(9):e73064. PubMed ID: 24023810 [TBL] [Abstract][Full Text] [Related]
17. Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3. Wang J; Sanmamed MF; Datar I; Su TT; Ji L; Sun J; Chen L; Chen Y; Zhu G; Yin W; Zheng L; Zhou T; Badri T; Yao S; Zhu S; Boto A; Sznol M; Melero I; Vignali DAA; Schalper K; Chen L Cell; 2019 Jan; 176(1-2):334-347.e12. PubMed ID: 30580966 [TBL] [Abstract][Full Text] [Related]
18. Fibrinogen-Like Protein 1 Modulates Sorafenib Resistance in Human Hepatocellular Carcinoma Cells. Son Y; Shin NR; Kim SH; Park SC; Lee HJ Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069373 [TBL] [Abstract][Full Text] [Related]
19. The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Li JJ; Wang JH; Tian T; Liu J; Zheng YQ; Mo HY; Sheng H; Chen YX; Wu QN; Han Y; Liao K; Pan YQ; Zeng ZL; Liu ZX; Yang W; Xu RH; Ju HQ Nat Commun; 2023 Oct; 14(1):6690. PubMed ID: 37872170 [TBL] [Abstract][Full Text] [Related]
20. The suppression of hepatic glucose production improves metabolism and insulin sensitivity in subcutaneous adipose tissue in mice. Casteras S; Abdul-Wahed A; Soty M; Vulin F; Guillou H; Campana M; Le Stunff H; Pirola L; Rajas F; Mithieux G; Gautier-Stein A Diabetologia; 2016 Dec; 59(12):2645-2653. PubMed ID: 27631137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]